PNN DigitalPNN Digital
    Facebook Twitter Instagram
    Tuesday, June 24
    Trending
    • Shaping the Future: The 2025 Indian Business Excellence Award Winners
    • Moving Media Entertainment Limited IPO Opens on June 26, 2025
    • Pushpa Jewellers Limited IPO Opens on June 30, 2025
    • AVP Infracon Secures Infra Work Order Worth Rs 33.34 Cr from Reliance Mappedu Multi Modal Logistics Park
    • Steris Healthcare: Reimagining Indian Pharma with Precision, Purpose, and People-First Care
    • Mast Banarasi Paan: India’s First and Fastest-Growing Tobacco-Free Paan Franchise Expands to 400+ Outlets
    • Midora Steam Oven’s Revolutionary Steam Technology by Hafele
    • Cosmic Scanner Launches the Ultimate Online Group Trip Marketplace for Young Adults
    Submit News
    PNN DigitalPNN Digital
    Subscribe
    • Home
    • News
    • Business
    • Entertainment
    • National
    • Lifestyle
    • More
      • Sports
      • Health
      • Finance
      • Education
    PNN DigitalPNN Digital
    Home»Business

    Medico Remedies Announces Robust Financial Performance For Q2 FY 2024

    Medico Remedies Reports Strong Financial Growth in Q2 FY2024, Reinforcing Its Industry Leadership
    Naquiyah MaimoonNaquiyah Maimoon Business 2 Mins Read
    Medico
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Mumbai (Maharashtra) [India], December 24: Medico Remedies Limited, a trusted name in the pharmaceutical industry, announced robust financial financial performance for the quarter ended September 2024.

    Medico Remedies registered a total income of Rs. 400.27 million for the second quarter and a net profit of Rs. 15.56 million. The company’s EPS for the quarter stood at Rs. 0.19, while profit before tax was Rs. 21.32 million. The operating profit margin and net profit margin for the quarter were 7.86% and 3.95% respectively.

    Haresh Mehta, Chairman of Medico Remedies Limited, said, “We are pleased with our financial results for the second quarter. Despite challenging market conditions, we have managed strong revenue and profit performance. We are well-positioned to benefit from the opportunities the fast-growing pharmaceuticals business offers and are confident of improving our financial performance in the coming quarters.”

    Medico

    Medico Remedies is focused on expanding its market presence and is actively pursuing growth opportunities within the sector. It remains committed to providing high-quality medicines and healthcare solutions at affordable prices.

    Headquartered in Mumbai, Medico Remedies is a leading player in the pharmaceutical sector with manufacturing and marketing capabilities in formulation with a focus on anti-infective, beta-lactams, cephalosporins, antimalarial, antiretroviral, anti-ulcer drugs and antacids, vitamins, haematinics and other supplements.

    Medico Remedies also has manufacturing capabilities in other drugs such as NSAIDs, antihistaminics, anti-diabetics, cardiovascular drugs, diuretics, anti-epileptics, combination drug kits, syrups, creams and gels for various therapeutic segments. Established in 1994, the company is known for its commitment to innovation, quality assurance and customer satisfaction.

    Medico

    Medico Remedies’ market cap stood at Rs. 424.55 crore as of Monday, December 23. The company’s shares closed at Rs. 51.16 on the BSE.

    If you have any objection to this press release content, kindly contact [email protected] to notify us. We will respond and rectify the situation in the next 24 hours.

    Financial Performance Medico Remedies Q2 FY 2024 Robust Financial
    Naquiyah Maimoon

    Keep Reading

    Shaping the Future: The 2025 Indian Business Excellence Award Winners

    Moving Media Entertainment Limited IPO Opens on June 26, 2025

    Pushpa Jewellers Limited IPO Opens on June 30, 2025

    AVP Infracon Secures Infra Work Order Worth Rs 33.34 Cr from Reliance Mappedu Multi Modal Logistics Park

    Steris Healthcare: Reimagining Indian Pharma with Precision, Purpose, and People-First Care

    Mast Banarasi Paan: India’s First and Fastest-Growing Tobacco-Free Paan Franchise Expands to 400+ Outlets

    Recent Posts
    • Shaping the Future: The 2025 Indian Business Excellence Award Winners
    • Moving Media Entertainment Limited IPO Opens on June 26, 2025
    • Pushpa Jewellers Limited IPO Opens on June 30, 2025
    • AVP Infracon Secures Infra Work Order Worth Rs 33.34 Cr from Reliance Mappedu Multi Modal Logistics Park
    • Steris Healthcare: Reimagining Indian Pharma with Precision, Purpose, and People-First Care

    Shaping the Future: The 2025 Indian Business Excellence Award Winners

    24/06/2025

    Moving Media Entertainment Limited IPO Opens on June 26, 2025

    24/06/2025

    Pushpa Jewellers Limited IPO Opens on June 30, 2025

    24/06/2025

    AVP Infracon Secures Infra Work Order Worth Rs 33.34 Cr from Reliance Mappedu Multi Modal Logistics Park

    24/06/2025

    Steris Healthcare: Reimagining Indian Pharma with Precision, Purpose, and People-First Care

    24/06/2025

    Mast Banarasi Paan: India’s First and Fastest-Growing Tobacco-Free Paan Franchise Expands to 400+ Outlets

    24/06/2025
    Facebook Instagram Twitter
    • Legal Disclaimer
    • Privacy Policy
    • Contact Us
    • About Us
    © 2025 PNN Digital. Designed by Primex Media Services.

    Type above and press Enter to search. Press Esc to cancel.